Advantage Multi For Cats is a drug owned by ELANCO US INC. It is protected by 4 US drug patents filed in 2015. All patents have expired. Details of Advantage Multi For Cats’s patents and their expiration are given below.
Exclusivity Information
Advantage Multi For Cats holds 2 exclusivitys out of which 2 have expired. Details of Advantage Multi For Cats's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 31, 2016 |
| ODE | Oct 31, 2020 |
About Advantage Multi For Cats
Advantage Multi For Cats is a drug
owned by ELANCO US INC.
Advantage Multi For Cats uses
Imidacloprid, Moxidectin as the active
ingredients.
Active Ingredient:
Advantage Multi For Cats uses
Imidacloprid,
Moxidectin
as the active ingredients.
Check out other Drugs and Companies using
Imidacloprid, Moxidectin ingredient.